Učitavanje...
Treatment of Diabetic Kidney Disease: Current and Future
Diabetic kidney disease (DKD) is the major cause of end-stage kidney disease. However, only renin-angiotensin system inhibitor with multidisciplinary treatments is effective for DKD. In 2019, sodium-glucose cotransporter 2 (SGLT2) inhibitor showed efficacy against DKD in Canagliflozin and Renal Even...
Spremljeno u:
| Izdano u: | Diabetes Metab J |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Korean Diabetes Association
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7850867/ https://ncbi.nlm.nih.gov/pubmed/33508907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2020.0217 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|